Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach

Autor: Marks, S, Naidoo, J

Publikováno v: In Lung Cancer January 2022 163:59-68

Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors.

Autor: Naidoo J; RCSI University of Medicine and Health Sciences, Beaumont RCSI Cancer Centre, Dublin 9, Ireland.; Beaumont Hospital Dublin, Beaumont RCSI Cancer Centre, Dublin 9, Ireland.; Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins University, Baltimore, MD 21287, United States., Johnson DB; Vanderbilt University Medical Center, Nashville, TN 37232, United States., Doran C; ConcertAI, LLC, Cambridge, MA 02138, United States., Wang Y; ConcertAI, LLC, Cambridge, MA 02138, United States., Zhang Y; Bristol Myers Squibb, Princeton, NJ 08540, United States., Le TK; Bristol Myers Squibb, Princeton, NJ 08540, United States., Hopson S; Bristol Myers Squibb, Princeton, NJ 08540, United States., Dreyfus B; Bristol Myers Squibb, Princeton, NJ 08540, United States., Lal LS; ConcertAI, LLC, Cambridge, MA 02138, United States., Vyas C; Bristol Myers Squibb, Princeton, NJ 08540, United States., Goldstein S; Bristol Myers Squibb, Princeton, NJ 08540, United States., Izadi Z; Bristol Myers Squibb, Princeton, NJ 08540, United States.

Publikováno v: The oncologist [Oncologist] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.

An African perspective on genetically diverse human induced pluripotent stem cell lines.

Autor: Hurrell T; Bioengineering and Integrated Genomics Group, Council for Scientific and Industrial Research, Pretoria, South Africa., Naidoo J; Bioengineering and Integrated Genomics Group, Council for Scientific and Industrial Research, Pretoria, South Africa.; Department of Human Biology, University of Cape Town, Cape Town, South Africa., Ntlhafu T; Bioengineering and Integrated Genomics Group, Council for Scientific and Industrial Research, Pretoria, South Africa., Scholefield J; Bioengineering and Integrated Genomics Group, Council for Scientific and Industrial Research, Pretoria, South Africa. jscholefield@csir.co.za.; Department of Human Biology, University of Cape Town, Cape Town, South Africa. jscholefield@csir.co.za.; Division of Human Genetics, University of the Witwatersrand, Johannesburg, South Africa. jscholefield@csir.co.za.

Publikováno v: Nature communications [Nat Commun] 2024 Oct 03; Vol. 15 (1), pp. 8581. Date of Electronic Publication: 2024 Oct 03.

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

Autor: Gainor, J.F., Rizvi, H., Jimenez Aguilar, E., Skoulidis, F., Yeap, B.Y., Naidoo, J., Khosrowjerdi, S., Mooradian, M., Lydon, C., Illei, P., Zhang, J., Peterson, R., Ricciuti, B., Nishino, M., Roth, J.A., Grishman, J., Anderson, D., Little, B.P., Carter, B.W., Arbour, K., Sauter, J.L., Mino-Kenudson, M., Heymach, J.V., Digumarthy, S., Shaw, A.T., Awad, M.M., Hellmann, M.D.

Publikováno v: In Annals of Oncology March 2020 31(3):404-411

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures.

Autor: Kao CJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Charmsaz S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Alden SL; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Brancati M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Li HL; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Balaji A; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Munjal K; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Howe K; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Mitchell S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Leatherman J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Griffin E; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Nakazawa M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Tsai HL; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Danilova L; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Convergence Institute and.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA., Thoburn C; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Gizzi J; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Gross NE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Hernandez A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Coyne EM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Shin SM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Babu JS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Apostol GW; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Durham J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Christmas BJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA., Konig MF; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lipson EJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Naidoo J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Beaumont Hospital, Dublin, Ireland.; RCSI University of Health Sciences, Dublin, Ireland., Cappelli LC; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Pabani A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ged Y; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Baretti M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Brahmer J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA., Hoffman-Censits J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Seiwert TY; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Garonce-Hediger R; F. Hoffmann-La Roche Ltd., a member of the imCORE network, Basel, Switzerland., Guha A; Genentech Inc., a member of the imCORE network, South San Francisco, California, USA., Bansal S; Genentech Inc., a member of the imCORE network, South San Francisco, California, USA., Tang L; Genentech Inc., a member of the imCORE network, South San Francisco, California, USA., Jaffee EM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Convergence Institute and.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA., Chandler GS; F. Hoffmann-La Roche Ltd., a member of the imCORE network, Basel, Switzerland., Mohindra R; F. Hoffmann-La Roche Ltd., a member of the imCORE network, Basel, Switzerland., Ho WJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Convergence Institute and., Yarchoan M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Convergence Institute and.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Aug 29; Vol. 134 (20). Date of Electronic Publication: 2024 Aug 29.